Considering its functional roles, ANXA1 contributes to chemoresistance, mainly to 5-fluorouracil (5-FU), a fundamental chemotherapeutic agent used in the management of both RC and colon cancers [25,26]. The gene discussed is ANXA1; the disease is colonic neoplasm.